Lexicon Pharma (LXRX) Announces Sotagliflozin Phase 3 in T1D Met Primary Endpoint
Go back to Lexicon Pharma (LXRX) Announces Sotagliflozin Phase 3 in T1D Met Primary Endpoint| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 1.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.63 | 52 Week High | $19.62 | |||
| Open | $1.63 | 52 Week Low | $7.65 | |||
| Day High | $1.69 | P/E | N/A | |||
| Day Low | $1.60 | EPS | $-0.22 | |||
| Volume | 2,518,229 | |||||
